Skip to main content
. 2018 Nov 12;16:310. doi: 10.1186/s12967-018-1682-5

Table 2.

Univariate and multivariate Cox regression analyses of the risk genes for non-small cell lung cancer brain metastasis

Factorsa HR 95% CI P value
Univariate analysis
 BMI1 0.58 0.29–1.16 0.124
 POU5F1 0.75 0.38–1.47 0.397
 KLF4 1.11 0.57–2.18 0.757
 SMO 0.86 0.43–1.68 0.650
 JAG1 0.85 0.43–1.67 0.634
 SPARC 1.44 0.73–2.84 0.292
 ST6GALNAC5 1.90 0.95–3.81 0.071
 SNAI1 1.89 0.96–3.74 0.066
 TNF 1.23 0.63–2.41 0.545
 CXCR5 0.77 0.39–1.51 0.448
 GFAP 1.00 0.51–1.96 0.995
 DYNC1LI2 1.13 0.58–2.21 0.729
 MMP3 1.21 0.62–2.37 0.579
 CDH2 1.87 0.94–3.71 0.073
 EGFR 0.65 0.33–1.28 0.212
 VCAN 1.50 0.76–2.97 0.247
 HGF 0.76 0.39–1.50 0.427
 CTNNB1 0.76 0.39–1.50 0.428
 CXCR4 1.46 0.74–2.88 0.275
 KIF3A 1.47 0.74–2.89 0.269
 GPM6A 0.70 0.36–1.38 0.307
 HBEGF 0.95 0.48–1.86 0.869
 CXCL13 0.99 0.51–1.95 0.985
 TGFB2 0.92 0.47–1.80 0.803
 PLP1 0.81 0.39–1.69 0.568
 TWIST1 1.45 0.74–2.86 0.280
 PTGS2 0.87 0.44–1.71 0.679
 BPTF 0.77 0.39–1.52 0.443
 FABP7 1.92 0.96–3.83 0.066
 GAP43 2.12 1.09–4.13 0.027
 PMP2 2.12 1.05–4.30 0.036
 UGT8 1.23 0.63–2.41 0.549
 GPM6B 1.00 0.51–1.96 0.990
 FAM107A 0.62 0.31–1.23 0.169
 IL8 1.27 0.65–2.49 0.492
 MMP9 1.16 0.59–2.27 0.668
Multivariate analysisb
 GAP43 3.29 1.55–7.00 0.002
 SNAI1 1.98 1.00–3.95 0.051
 Grade 2.08 1.00–4.34 0.051

HR hazard ratio, CI confidence interval

Italic values were statistically significant (P < 0.05)

aFactors were analyzed as categorical variables, and low-expression groups or well-differentiated groups were referred

bGenes whose P values were < 0.1 in univariate analyses and clinicopathologic factors were involved in the multivariate Cox regression analysis, and the Forward LR (based on partial maximum likelihood estimation) was used to identify independent risk factors